See All Authors »

James Brumley

Contributing Writer
Kiplinger.com

James Brumley is a former stock broker, registered investment adviser and Director of Research for an options-focused newsletter. He's now primarily a freelance writer, tapping more than a decade's worth of broad experience to help investors get more out of the market. With a background in technical analysis as well as fundamental analysis, James touts stock-picking strategies that combine the importance of company performance with the power of stock-trade timing. He believes this dual approach is the only way an investor has a shot at consistently beating the market. James' work has appeared at several websites including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multi-pronged approach to investing.

Latest Features

SLIDE SHOW
November 2018

5 Dow Stocks to Sell (And 2 to Buy)

Most stocks have been thoroughly shaken and stirred since early October, and a long-overdue corrective move finally took shape. Not even the bluest of the blue chips have been immune. The Dow Jones Industrial ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2018

7 Great Companies You Could Buy If You Win Mega Millions

Most people have already mapped out their spending plans for a Mega Millions jackpot they’ll never actually win. Visions of big boats, sports cars and luxurious houses can become reality just by picking ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2018

What Happens When a Retailer Goes Bankrupt?

Just when it looked like the so-called retail apocalypse was all the way in the rearview mirror, it managed to claim another victim. A long-beleaguered Sears Holdings (SHLDQ, $0.40) finally was forced ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2018

12 Vulnerable Stocks to Watch on Market-Wide Weakness

Several companies that have been red-hot over the past few months have suddenly become stocks to watch for all the wrong reasons. Stocks do suffer setbacks from time to time. Too many investors have ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2018

5 "Warren Buffett Stocks" That Might Not Be His Ideas

Warren Buffett is one of the most successful investors (if not the most) of all time, and chief stock-picker for Berkshire Hathaway (BRK.B). Since assembling the group of companies that would eventually ...

See More From: Stocks & Bonds

SLIDE SHOW
October 2018

12 Large-Cap Stocks With Must-Watch Q3 Earnings Reports

The third-quarter earnings season is upon us. Alcoa (AA), which used to be the unofficial harbinger of the season, will post its Q3 results on Oct. 17 … but a handful of big-name large-cap stocks will ...

See More From: Stocks & Bonds

SLIDE SHOW
September 2018

5 Blue-Chip "Marijuana Stocks"

The legality of cannabis – marijuana – within the United States is a gray area. It’s illegal in all forms at a federal level, but the nation’s Drug Enforcement Agency and other law-enforcement ...

See More From: Stocks & Bonds

SLIDE SHOW
September 2018

7 Best Biotech Stocks for Investors Who Hate Risk

Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky. Far too many horror stories of failed drug trials or the ...

See More From: Stocks & Bonds

SLIDE SHOW
September 2018

10 Companies Already Hurt by President Trump's Tariffs

If steep tariffs on goods imported into the United States are only part of a negotiating tactic from President Donald Trump, he certainly has committed to his bluff. Trump’s tariffs – the first of ...

See More From: Stocks & Bonds

SLIDE SHOW
September 2018

12 Top Stock Picks to Shield Your Portfolio

The stock market is a running milestone. We’re currently in the longest-ever bull market – a fact that became official on Wednesday, Aug. 22, when it became 3,453 days old. Some have shrugged off the ...

See More From: Stocks & Bonds

SLIDE SHOW
September 2018

49 Companies Amazon Could Destroy (And 1 It Already Has)

You would think e-commerce and cloud computing giant Amazon.com (AMZN), after 20 years of unfettered growth, would have run out of room to pump up its top line. But the company continues to choose new ...

See More From: Stocks & Bonds

SLIDE SHOW
August 2018

7 Struggling Companies in Retreat Mode

The economy's as strong as it's been in years, and corporate earnings have collectively been even better than expected. By all accounts, companies—all companies—should be thriving. And most are. Not ...

See More From: Stocks & Bonds

Stock Watch
August 2018

Does Apple’s $1 Trillion Benchmark Even Matter?

Wall Street collectively pointed and stared at the big, round number. But experts don’t agree on what it means for AAPL stock.

See More From: Stock Watch

SLIDE SHOW
August 2018

7 Tesla (TSLA) Risks That Investors Can’t Ignore

Give credit where it’s due. Tesla Inc. (TSLA, $300.84) CEO Elon Musk, through sheer willpower and persistence, has mainstreamed the idea of electric vehicles. EVs were a fringe project taken on by only ...

See More From: Investor Psychology

SLIDE SHOW
July 2018

10 of the Market’s Most Shorted Stocks

When can negativity be used for something positive? Well, in the market, a quick look at the most shorted stocks could unearth potential. The typical investor’s approach to the market is buying low, ...

See More From: Stocks & Bonds

SLIDE SHOW
July 2018

7 Former Dow Jones Stocks That Survived "The Boot"

Once-great industrial giant General Electric (GE) was removed as a constituent of the Dow Jones Industrial Average in June 2018. Although GE was a component of the blue-chip index for 110 years, time finally ...

See More From: Stocks & Bonds

SLIDE SHOW
July 2018

10 Cancer-Fighting Health Care Stocks to Buy

Cancer. The mere mention of the word can drudge up discomfort, as most everyone knows it’s second only to heart disease when it comes to claiming lives. Unlike heart disease, though, cancer is difficult ...

See More From: Stocks & Bonds

Show More Stories